A takeout could remove CAR T play Legend from Biosecure’s glare

Should a rumored acquisition of Legend come to fruition, the deal could offer the CAR T company a “Get Out of Jail Free” card as far as it comes to scrutiny under the Biosecure Act.

The House Select Committee on the Chinese Communist Party has recently signaled its interest in Legend Biotech Corp. (NASDAQ:LEGN) and its largest shareholder, GenScript Biotech Corp. (HKEX:1548), requesting a briefing on May 30 from the Office of the Director of National Intelligence and the FBI about “potential risks they pose to U.S. national security, and the implications of their efforts to displace U.S. leadership in the biotechnology sector.” ...